Tiina Kahkonen

Chief Scientific Officer at OncoBone Ventures Ltd

Presenter

OncoBone Ventures develops novel therapies for cancer patients with bone metastases utilising our novel innovative osteoimmuno-oncology (OIO) concept. We identify potential OIO drug candidates from academic institutions and confirm their efficacy in our preclinical Bone Metastasis Technology Platform, followed by safety testing of effective assets in GLP-toxicity studies and completing IND-ready packages for outlicensing to larger pharma/biotech companies for clinical development.